Slide 1: Cigna and Express Scripts: Expands Growth Opportunities
CIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE March 2018
Slide 2: Important Information for Investors and Shareholders: Forward Looking Statements
Important Information for Investors and Shareholders FORWARD LOOKING STATEMENTS Information included or incorporated by reference in this communication, and information which may be contained in other filings with the Securities and Exchange Commission (the “SEC”) and press releases or other public
Slide 3: Important Information About the Transaction and Where to Find It
Important Information for Investors and Shareholders IMPORTANT INFORMATION ABOUT THE TRANSACTION AND WHERE TO FIND IT This communication does not constitute an offer to buy or solicitation of an offer to sell any securities. In connection with the proposed transaction, the newly formed company which
Slide 4: Important Information: Non-GAAP Measures
Important Information for Investors and Shareholders NON-GAAP MEASURES Throughout this presentation, we use financial measures when describing financial results and outlook that are not determined in accordance with accounting principles generally accepted in the United States of America (“GAAP”). A
Slide 5: Addressing the evolving needs of a dynamic healthcare market
Addressing the evolving needs of a dynamic healthcare market • Mid-teens EPS accretion in year 1 Deliver Differentiated • Increased 2021 EPS target to $20 - $21 per share Financial Results • Outstanding free cash flow • Best-in-class medical and pharmacy cost trends Further Improve • Further expand
Slide 6: Delivers Differentiated Financial Results and Shareholder Value
Delivers Differentiated Financial Results and Shareholder Value • Mid-teens accretion in first full year post-close, excluding any contribution from Drives Strong Express Scripts’ transitioning clients EPS Accretion • Increasing 2021 EPS target to $20-$21 Delivers Immediate • Greater than ~$600 mill
Slide 7: Billions of savings will further improve affordability
Billions of savings will further improve affordability Lowest medical Industry-leading cost trend for 5 pharmaceutical cost consecutive years trend in 2017 • Pharmacy is currently the #1 gap in care for customers and is ~20% of the total medical spend and growing • Specialty pharmacy is the fastest
Slide 8: Poised for Sustained Growth – by Expanding our Reach
Poised for Sustained Growth – by Expanding our Reach Advance pharmacy penetration Access to employer middle market Meaningfully expand geographic reach Broaden offerings for employers, health Strengthened Medicare Advantage and Part D offerings plans and government agencies Deepens and strengthens c
Slide 9: Three Attractive, Well-Positioned Growth Platforms
Three Attractive, Well-Positioned Growth Platforms U.S. Integrated Medical U.S. Integrated Services Global and Individual Platform Platforms Targeting Cigna’s “Go Deeper” Leading globally mobile, employer National scope targeting employers of geographies and individual solutions all sizes, health pl
Slide 10: Shaping the healthcare landscape of tomorrow, today
Shaping the healthcare landscape of tomorrow, today Optimizing Designing Care Personalized Leveraging technology and data to enhance care Solutions Offering a full suite of delivery and improve medical, behavioral, outcomes pharmacy, specialty pharmacy and other health engagement services Creating V